tetano
Editor, Senior Moderator
Neurol Sci
. 2020 Jul 9.
doi: 10.1007/s10072-020-04553-9. Online ahead of print.
Is Guillain-Barr? Syndrome Triggered by SARS-CoV-2? Case Report and Literature Review
Edoardo Agosti[SUP] 1 [/SUP], Andrea Giorgianni[SUP] 2 [/SUP], Francesco D'Amore[SUP] 2 [/SUP], Gabriele Vinacci[SUP] 3 [/SUP], Sergio Balbi[SUP] 4 [/SUP], Davide Locatelli[SUP] 4 [/SUP]
Affiliations
Abstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the infectious agent responsible for coronavirus disease 2019 (COVID-19). Respiratory and gastrointestinal manifestations of SARS-CoV-2 are well described, less defined is the clinical neurological spectrum of COVID-19. We reported a case of COVID-19 patient with acute monophasic Guillain-Barr? syndrome (GBS), and a literature review on the SARS-CoV-2 and GBS etiological correlation.
Case description: A 68 years-old man presented to the emergency department with symptoms of acute progressive symmetric ascending flaccid tetraparesis. Oropharyngeal swab for SARS-CoV-2 tested positive. Neurological examination showed bifacial nerve palsy and distal muscular weakness of lower limbs. The cerebrospinal fluid assessment showed an albuminocytologic dissociation. Electrophysiological studies showed delayed distal latencies and absent F waves in early course. A diagnosis of Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP) subtype of GBS was then made.
Conclusions: Neurological manifestations of COVID-19 are still under study. The case we described of GBS in COVID-19 patient adds to those already reported in the literature, in support of SARS-CoV-2 triggers GBS. COVID-19 associated neurological clinic should probably be seen not as a corollary of classic respiratory and gastrointestinal symptoms, but as SARS-CoV-2-related standalone clinical entities. To date, it is essential for all Specialists, clinicians and surgeons, to direct attention towards the study of this virus, to better clarify the spectrum of its neurological manifestations.
Keywords: AIDP; COVID-19; Guillain-Barr?; Neuropathy; Para-infectious; SARS-CoV-2.
. 2020 Jul 9.
doi: 10.1007/s10072-020-04553-9. Online ahead of print.
Is Guillain-Barr? Syndrome Triggered by SARS-CoV-2? Case Report and Literature Review
Edoardo Agosti[SUP] 1 [/SUP], Andrea Giorgianni[SUP] 2 [/SUP], Francesco D'Amore[SUP] 2 [/SUP], Gabriele Vinacci[SUP] 3 [/SUP], Sergio Balbi[SUP] 4 [/SUP], Davide Locatelli[SUP] 4 [/SUP]
Affiliations
- PMID: 32643136
- DOI: 10.1007/s10072-020-04553-9
Abstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the infectious agent responsible for coronavirus disease 2019 (COVID-19). Respiratory and gastrointestinal manifestations of SARS-CoV-2 are well described, less defined is the clinical neurological spectrum of COVID-19. We reported a case of COVID-19 patient with acute monophasic Guillain-Barr? syndrome (GBS), and a literature review on the SARS-CoV-2 and GBS etiological correlation.
Case description: A 68 years-old man presented to the emergency department with symptoms of acute progressive symmetric ascending flaccid tetraparesis. Oropharyngeal swab for SARS-CoV-2 tested positive. Neurological examination showed bifacial nerve palsy and distal muscular weakness of lower limbs. The cerebrospinal fluid assessment showed an albuminocytologic dissociation. Electrophysiological studies showed delayed distal latencies and absent F waves in early course. A diagnosis of Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP) subtype of GBS was then made.
Conclusions: Neurological manifestations of COVID-19 are still under study. The case we described of GBS in COVID-19 patient adds to those already reported in the literature, in support of SARS-CoV-2 triggers GBS. COVID-19 associated neurological clinic should probably be seen not as a corollary of classic respiratory and gastrointestinal symptoms, but as SARS-CoV-2-related standalone clinical entities. To date, it is essential for all Specialists, clinicians and surgeons, to direct attention towards the study of this virus, to better clarify the spectrum of its neurological manifestations.
Keywords: AIDP; COVID-19; Guillain-Barr?; Neuropathy; Para-infectious; SARS-CoV-2.